IAR Systems Group AB Årsredovisning 2014
March 26, 2015 08:00 ET | I.A.R Systems Group AB
IAR Systems Group AB (publ) publicerar idag årsredovisning för 2014 på bolagets webbplats www.iar.com/investerare. Årsstämma hålls onsdagen 29 april klockan 18.00 på Lundqvist och Lindqvist,...
BioBlastLogo.jpg
BioBlast Pharma Announces Positive Preclinical Proof-of-Concept Results of Its Novel Mitochondrial Protein Replacement Platform in Friedreich's Ataxia
March 26, 2015 08:00 ET | Bioblast Pharma Ltd.
TEL AVIV, Israel, March 26, 2015 (GLOBE NEWSWIRE) -- BioBlast Pharma Ltd. (Nasdaq:ORPN), a clinical-stage, orphan disease-focused biotechnology company announced today positive preclinical in vitro...
logo_2-180x80.png
Spine Pain Management Schedules Interactive Conference Call to Present Full Year 2014 Financial Results and Provide Business Development Update
March 26, 2015 08:00 ET | Spine Injury Solutions, Inc.
HOUSTON, March 26, 2015 (GLOBE NEWSWIRE) -- Spine Pain Management, Inc. (OTCQB:SPIN), a technology-driven, medical service, device and healthcare solution company servicing the multi-billion dollar...
UBIC Obtains New Jap
UBIC Obtains New Japanese Patent for Technology Related To Behavior Informatics
March 26, 2015 08:00 ET | FRONTEO
TOKYO, March 26, 2015 (GLOBE NEWSWIRE) -- UBIC, Inc. (Nasdaq:UBIC) (TSE:2158) ("UBIC" or "the Company"), a leading provider of international litigation support and big-data analysis services, today...
Kite Pharma Reports
Kite Pharma Reports Full-Year and Fourth Quarter 2014 Financial Results
March 26, 2015 08:00 ET | Kite Pharma, Inc.
SANTA MONICA, Calif., March 26, 2015 (GLOBE NEWSWIRE) -- Kite Pharma, Inc. (Kite) (Nasdaq:KITE), a clinical-stage biopharmaceutical company focused on developing engineered autologous T cell therapy...
Novavax logo
Novavax Prices Public Offering of Common Stock
March 26, 2015 08:00 ET | Novavax, Inc.
GAITHERSBURG, Md., March 26, 2015 (GLOBE NEWSWIRE) -- Novavax, Inc. (Nasdaq:NVAX), a clinical-stage vaccine company focused on the discovery, development and commercialization of recombinant...
SCV banner.jpg
Brady Granier, Chief Operating Officer and Interim Chief Executive Officer of BioCorRx, Inc., Discusses Recent News in a New Audio Interview at SmallCapVoice.com
March 26, 2015 08:00 ET | SmallCapVoice.com
AUSTIN, Texas, March 26, 2015 (GLOBE NEWSWIRE) -- SmallCapVoice.com, Inc. (SCV) announced today that a new audio interview with BioCorRx, Inc. (OTC QB:BICX), developer of the Start Fresh Program, is...
Neothetics Reports F
Neothetics Reports Fourth Quarter and Full Year 2014 Financial Results
March 26, 2015 08:00 ET | Neothetics, Inc.
SAN DIEGO, March 26, 2015 (GLOBE NEWSWIRE) -- Neothetics, Inc. (Nasdaq:NEOT), a clinical-stage specialty pharmaceutical company developing therapeutics for the aesthetic market, today reported...
ERBA Diagnostics Ent
ERBA Diagnostics Enters Agreement to Sell Former Facilities for $23 Million
March 26, 2015 08:00 ET | ERBA Diagnostics, Inc.
MIAMI LAKES, Fla., March 26, 2015 (GLOBE NEWSWIRE) -- ERBA Diagnostics, Inc. (NYSE MKT:ERB) announced that its wholly-owned subsidiary – Diamedix Corporation – has entered into a purchase...
Immune Design Logo
Immune Design Announces Treatment of Patients With CMB305 Investigational Immuno-Oncology Agent
March 26, 2015 08:00 ET | Immune Design Corp.
Prime-Boost in vivo T cell active immunotherapy SEATTLE and SOUTH SAN FRANCISCO, Calif., March 26, 2015 (GLOBE NEWSWIRE) -- Immune Design (Nasdaq:IMDZ), a clinical-stage immunotherapy company...